Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results


1.		Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				KSP20007 NCT00085813


2.		Study Of Ispinesib In Subjects With Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				KSP20001 NCT00089973

Last Modified: 1/18/2008 First Published: 10/25/2004


3.		Phase II Study of SB-715992 in Patients With Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CAN-NCIC-IND168 NCIC-168, NCT00095992, IND168

Last Modified: 11/13/2007 First Published: 10/25/2004


4.		Phase II Study of SB-715992 in Patients With Previously Untreated Metastatic or Recurrent Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CAN-NCIC-IND169 NCIC-169, NCT00095953, IND169

Last Modified: 1/24/2007 First Published: 10/25/2004


5.		Phase II Study of SB-715992 in Patients With Taxane-Resistant, Androgen-Independent Metastatic Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				SWOG-S0418 S0418, NCT00096499

Last Modified: 12/12/2006 First Published: 10/25/2004


6.		Phase II Study of SB-715992 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				PMH-PHL-031 NCI-6803, 6803, NCT00095628


7.		Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Pharmaceutical / Industry				KSP20008 NCT00097409

Last Modified: 7/18/2007 First Published: 1/24/2005


8.		Phase II Randomized Study of SB-715992 in Patients With Advanced or Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				CCC-PHII-51 6800, NCI-6800, NCT00103311

Last Modified: 7/31/2008 First Published: 7/14/2006


9.		Phase II Study of Ispinesib (SB-715992) in Patients With Metastatic or Unresectable Renal Cell Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Not specified				NCI				CCUM-14577A 7673, NCI-7673, NCT00354250

Last Modified: 5/24/2008 First Published: 11/22/2004


10.		Phase I Study of SB-715992 in Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				CASE-CWRU-3904 NCI-6777, 6777, NCT00098826, CWRU-070418, CASE-3904

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute